Finland – Pharmaceutical products – Aflibercept preparations (S01LA05) for the procurement period 1 January to 31 December 2027
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The procurement concerns the ATC group S01LA05 aflibercept injectable medicinal products intended for adults in Finland, which are marketed and available in Finland on January 1, 2027. Due to the nature of the acquisition, its exact value cannot be announced in advance. In the announcement, both the total value of the purchase and the value of the contract are stated as 1e, because the contract price is encrypted and only one finished product has been selected.